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Tuberculin skin testing in white-tailed deer (Odocoileus virginianus)
Mitchell V. Palmer, Diana L. Whipple, W. Ray Waters
Abstract. The comparative cervical skin test for antemortem diagnosis of tuberculosis was done 169 times
on 116 different white-tailed deer of known Mycobacterium bovis infection status. The sensitivity and specificity
were 97 and 81%, respectively. The magnitude of change in skin thickness at test sites was not significantly
influenced by dosage of inoculum, dissemination of the disease process, or repeated skin testing. However, the
magnitude of change in skin thickness was significantly greater in deer infected for less than 109 days than in
deer infected for more than 109 days. As used in the present study, the comparative cervical skin test is a
sensitive method of antemortem diagnosis of M. bovis infection in white-tailed deer.
The captive Cervidae industry has grown remark-
ably in the United States over the last 20 years. The
North American Deer Farmers organization has over
400 active producer members that commercially
raise over 75,000 head of fallow (Dama dama), axis
(Axis axis), red (Cervus elaphus), white-tailed (Odo-
coileus virgninianus), or sika deer (Cervus nippon).
The North American Elk Breeders Association, with
over 1,700 members, estimates that there are over
From the Bacterial Diseases of Livestock Research Unit, National
Animal Disease Center, Agricultural Research Service, USDA,
Ames, IA 50010.
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150,000 farmed elk (Cervus elaphus) in the United
States.
Tuberculosis of captive Cervidae became an impor-
tant disease in the United States in 1990 and 1991,
when investigations were prompted by the identifica-
tion of a tuberculous elk in Canada that had been im-
ported from the United States in 1988. Testing of do-
mestic herds with links to the Canadian elk revealed
tuberculosis in 10 different elk herds in 8 different
states.2 The discovery of tuberculosis in captive elk in
the United States resulted in the addition of captive
Cervidae to the US Department of agriculture (USDA)
uniform methods and rules (UMR) for the eradication
of bovine tuberculosis.10 The inclusion of regulations
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for the eradication of tuberculosis in captive Cervidae
to the UMR is justified because it has been docu-
mented that captive Cervidae can represent a source
of infection for domestic cattle.3
Antemortem diagnosis of tuberculosis in animals
has relied on measurement of delayed-type hypersen-
sitivity (DTH) by intradermal injection of mycobac-
terial extracts, the most common of which is purified
protein derivative (PPD). Early investigation of intra-
dermal skin testing of Cervidae showed the caudal fold
test, as performed in cattle, to be unreliable in Cervi-
dae.9 Cervical skin testing, by injection of M. bovis
PPD in the skin of the lateral neck, was found to be
more reliable than caudal fold skin testing. Currently,
only intradermal skin testing and the blood tubercu-
losis (BTB) test are approved by the USDA for ante-
mortem diagnosis of tuberculosis in Cervidae.10 Cur-
rently, however, the BTB test is not available in the
United States.
Typically, Cervidae in a herd of unknown infection
status are tested by the single cervical tuberculin test
(SCT) and the results are categorized as negative, sus-
pect, or reactor. Suspects, as identified by the SCT,
may be reevaluated using the comparative cervical tu-
berculin test (CCT). The CCT involves injection of
PPD from M. bovis (bovine PPD) and Mycobacterium
avium (avian PPD) at 2 different sites on the lateral
neck. The addition of the avian PPD in the CCT in-
creases specificity as compared with the SCT. Animals
infected with atypical mycobacteria may be suspects
or reactors on the SCT; however, using the CCT, these
animals can often be identified due to a greater change
in skin thickness at the avian PPD injection site com-
pared with the change in skin thickness at the bovine
PPD injection site. Results of the CCT are then used
to categorize deer as negative, suspect, or reactor.
Little information exists on the accuracy of intra-
dermal skin testing for tuberculosis in individual spe-
cies of Cervidae. In New Zealand, the sensitivity of
the SCT in naturally or experimentally infected red
deer has been reported to be 82 and 86%, respective-
ly.1,4 Specificity has varied from 46 to 76% in herds
of tuberculosis-negative red deer.9 In a study limited
to experimentally infected red deer, the CCT had a
sensitivity and specificity of 91.4 and 98.7%, respec-
tively.9 In a separate evaluation of the CCT using nat-
urally infected fallow and sika deer, the sensitivity and
specificity were found to be 84 and 80%, respectively.5
In the United States, the specificity of the SCT in all
Cervidae is between 71 and 86%.9 The sensitivity is
reported to be 100%; however, SCT-negative animals
were not euthanized and examined; thus, the true in-
fection status of these animals is not known.9 In the
United States, where numerous species of Cervidae are
raised for commercial purposes, few studies have in-
vestigated the accuracy of intradermal tuberculin test-
ing in selected species of deer.
One hundred sixty-nine intradermal skin tests (CCT)
were conducted on 116 white-tailed deer of known
infection status. Sixty deer were confirmed infected
with M. bovis through thorough postmortem exami-
nation and bacteriologic culture of tissues. Forty-nine
of the known infected animals were part of tubercu-
losis pathogenesis studies and had been experimentally
infected, as described,8 with various dosages of M.
bovis, ranging from 300 colony-forming units (CFU)
to 2 3 108 CFU. Eleven deer were part of a tubercu-
losis transmission study and had been infected through
contact exposure to experimentally infected deer. My-
cobacterium bovis strain 1315, originally isolated from
a white-tailed deer in Michigan, was used for all ex-
perimental infections.
The CCT was done as described in USDA Animal
and Plant Health Inspection Service, Veterinary Ser-
vices guidelines.10 Hair was clipped from 2 sites on 1
side of the midcervical region and the skin thickness
of each site was measured. One tenth milliliter avian
PPD (0.4 mg/ml) was injected intradermally in the up-
permost site and 0.1 ml of bovine PPD (1 mg/ml) was
injected into the lower site. Injection sites were ob-
served, palpated, and measured 72 hours after injec-
tion. Results were interpreted by plotting measure-
ments on a graph (VS from 6-22D) developed by the
USDA for interpretation of the CCT for Cervidae.
Based on the results, animals were categorized as neg-
ative, suspect, or reactor. In addition to change in skin
thickness at the respective injection sites, other infor-
mation recorded included dosage of inoculum, classi-
fication of the resulting disease as disseminated or lo-
calized, number of tissue sites affected, duration of
infection, and isolation of atypical mycobacteria. Af-
fected tissues were those with gross or microscopic
lesions consistent with tuberculosis or tissues from
which M. bovis was isolated. As previously described,
lesion distribution was characterized as localized
(gross or microscopic lesions in 1 or more of the fol-
lowing sites: tonsils, oropharyngeal lymph nodes, tho-
racic lymph nodes, lung) or disseminated (gross or mi-
croscopic lesions in sites in addition to those seen in
localized disease).7 Means of parameters of interest
were compared using the Student’s t-test. Differences
were considered statistically significant when P ,
0.05.
One hundred sixty-nine tests were done on 116 deer.
Thirty-eight deer were tested twice, while 15 deer were
tested 3 times. Repeat tests were separated by a min-
imum of 90 days. Of 169 tests, 60 were done in known
M. bovis-infected deer, while 109 were done in known
noninfected deer. Of the 60 known M. bovis-infected
deer, the CCT identified 58 (97%) as reactors and 2
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(3%) as suspect. No M. bovis-infected deer were cat-
egorized as negative. The CCT identified 88 (81%)
noninfected deer as negative, 15 (14%) as suspect, and
6 (5%) as reactors.
As expected, the change in skin thickness at the bo-
vine PPD injection site was significantly greater in M.
bovis-infected deer than that seen in noninfected deer
(Table 1). While there was also a significant difference
in change in skin thickness between M. bovis-infected
deer and noninfected deer at the avian PPD injection
site, this difference was not sufficient to change the
categorization of the deer as reactor, suspect, or neg-
ative on the USDA graph. Mycobacterium avium or
other atypical mycobacteria were isolated from 3 deer.
The presence of atypical mycobacteria did cause the
DTH response to be larger at the avian PPD injection
site when compared with deer from which no myco-
bacteria were isolated; however, this response was not
statistically significant (Table 1). In 1 case, M. gastri
was isolated from a non-M. bovis-infected deer cate-
gorized as a reactor by the CCT.
In all experimentally infected deer, the duration of
infection could be precisely determined and ranged
from 90 to 365 days (mean 5 137, median 5 100).
Mean change in skin thickness at the bovine PPD in-
jection site was significantly greater in deer that had
been infected less than 109 days than those deer in-
fected for greater than 109 days (Table 1). Dissemi-
nation of the disease process was evaluated in 41 of
60 M. bovis-infected deer. There was no significant
difference in change in skin thickness at either the bo-
vine or avian PPD injection sites when deer with dis-
seminated tuberculosis (n 5 24) were compared with
deer with localized tuberculosis (n 5 17).
There was no significant difference in the change in
skin thickness at the bovine or avian PPD injection
sites between deer receiving high (.103 CFU) or low
(#103 CFU) dosages of M. bovis (Table 1). Repeated
testing of M. bovis-infected or noninfected deer did not
significantly alter the magnitude of the change in skin
thickness at the bovine PPD or avian PPD injection
sites or change the resulting categorization of the re-
sponse.
In the present study, the magnitude of the change in
skin thickness at the site of intradermal tuberculin skin
testing was not influenced by dosage of inoculum, dis-
semination of the disease process, or repeated skin
testing. All of the infected deer used in the present
study were experimentally infected with M. bovis or
were infected through contact with experimentally in-
fected deer. It is possible that results would vary in
naturally infected white-tailed deer.
Previous experiments in cattle and deer have shown
that, as M. bovis infection progresses, the immune re-
sponse is altered from one of primarily cell-mediated
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immunity to one of primarily antibody production.6
This results in diminution of delayed-type hypersen-
sitivity and an increase in serum antibody titers to var-
ious M. bovis antigens.10 In the present study, the cell-
mediated response, as measured by intradermal skin
testing, did not decrease as tuberculosis progressed to
a disseminated form. However, as the duration of in-
fection increased, the size of the reaction at the bovine
PPD injection site decreased, suggesting a change in
the cell-mediated immune response. Other assays to
measure cell-mediated or humoral immunity were not
considered in the present study.
In the current report, the CCT was not preceded by
the SCT, as described in the UMR for the eradication
of bovine tuberculosis. However, in testing captive
wildlife, when repeated handling, restraint, and risk of
injury to animals and personnel are problematic, it
may be appropriate, although not officially recom-
mended, to utilize the CCT as the initial screening test.
In spite of the technical difficulties associated with in-
tradermal tuberculin skin testing of Cervidae, the CCT
remains a sensitive and moderately specific means of
antemortem diagnosis of tuberculosis in white-tailed
deer. Although the ideal test is one with high sensitiv-
ity and specificity, in disease eradication schemes, it
may be appropriate to accept tests with high sensitivity
and only moderate specificity. In such a scenario, some
false-positive results and condemnation of uninfected
animals are tolerated while confidence is maintained
that few, if any, false-negative animals remain behind
to cause reinfection in tested herds.
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